FASLG and autoimmune polyendocrinopathy: More importantly, in this study, we found significantly higher levels of IgG aβ2GP1-D1 antibodies in patients with triple-positive aPL profile, further supporting the importance of IgG aβ2GP1-D1 antibodies in evaluation of the APS clinical risks.